Carbopol-olive oil-based bigel drug delivery system of doxycycline hyclate for the treatment of acne
OBJECTIVE: The objective of this study was to prepare and evaluate the doxycycline hyclate containing bigel for the effective treatment of acne.
METHODS: Bigels are biphasic systems formed by water-based hydrogels and oil-based organogel. Carbopol 940 was used to prepare the hydrogel phase, whereas Span-60 and olive oil for the oleogel phase.
RESULTS: The microstructure of bigel confirmed the oil in water type emulsion formation. The average droplet size of formulations was found 15-50 µm, and a bell-shaped droplet distribution curve, rheological, or viscosity studies suggested that the consistency and stability of bigel decrease with high organogel concentration. Three formulations (F1, F2, and F3) of the different ratios of hydrogel:oleogel (60:40, 70:30, and 80:20) were prepared in which F1 was less stable compared to F2 and F3. The drug content of F2 and F3 was respectively 79.94 and 71.33%. Formulation F2 was found more effective as compared to F3 based on in vitro drug release studies. Bigel also showed better results during in vivo studies at the rabbit ear model, which reduce acne diameter up to 1.10 mm from 4.9 mm while gel reduced it up to 1.20 mm.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Drug development and industrial pharmacy - 47(2021), 6 vom: 01. Juni, Seite 954-962 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Soni, Kumud [VerfasserIn] |
---|
Links: |
---|
Themen: |
0A5MM307FC |
---|
Anmerkungen: |
Date Completed 13.08.2021 Date Revised 25.04.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/03639045.2021.1957916 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328253618 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328253618 | ||
003 | DE-627 | ||
005 | 20231225202551.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/03639045.2021.1957916 |2 doi | |
028 | 5 | 2 | |a pubmed24n1094.xml |
035 | |a (DE-627)NLM328253618 | ||
035 | |a (NLM)34280061 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Soni, Kumud |e verfasserin |4 aut | |
245 | 1 | 0 | |a Carbopol-olive oil-based bigel drug delivery system of doxycycline hyclate for the treatment of acne |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.08.2021 | ||
500 | |a Date Revised 25.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: The objective of this study was to prepare and evaluate the doxycycline hyclate containing bigel for the effective treatment of acne | ||
520 | |a METHODS: Bigels are biphasic systems formed by water-based hydrogels and oil-based organogel. Carbopol 940 was used to prepare the hydrogel phase, whereas Span-60 and olive oil for the oleogel phase | ||
520 | |a RESULTS: The microstructure of bigel confirmed the oil in water type emulsion formation. The average droplet size of formulations was found 15-50 µm, and a bell-shaped droplet distribution curve, rheological, or viscosity studies suggested that the consistency and stability of bigel decrease with high organogel concentration. Three formulations (F1, F2, and F3) of the different ratios of hydrogel:oleogel (60:40, 70:30, and 80:20) were prepared in which F1 was less stable compared to F2 and F3. The drug content of F2 and F3 was respectively 79.94 and 71.33%. Formulation F2 was found more effective as compared to F3 based on in vitro drug release studies. Bigel also showed better results during in vivo studies at the rabbit ear model, which reduce acne diameter up to 1.10 mm from 4.9 mm while gel reduced it up to 1.20 mm | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Bigel | |
650 | 4 | |a acne | |
650 | 4 | |a carbopol 940 | |
650 | 4 | |a doxycycline hyclate | |
650 | 4 | |a olive oil | |
650 | 7 | |a Acrylic Resins |2 NLM | |
650 | 7 | |a Hydrogels |2 NLM | |
650 | 7 | |a Olive Oil |2 NLM | |
650 | 7 | |a carboxypolymethylene |2 NLM | |
650 | 7 | |a 0A5MM307FC |2 NLM | |
650 | 7 | |a Doxycycline |2 NLM | |
650 | 7 | |a N12000U13O |2 NLM | |
700 | 1 | |a Gour, Vishal |e verfasserin |4 aut | |
700 | 1 | |a Agrawal, Poornima |e verfasserin |4 aut | |
700 | 1 | |a Haider, Tanweer |e verfasserin |4 aut | |
700 | 1 | |a Kanwar, Indu Lata |e verfasserin |4 aut | |
700 | 1 | |a Bakshi, Avijit |e verfasserin |4 aut | |
700 | 1 | |a Soni, Vandana |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug development and industrial pharmacy |d 1994 |g 47(2021), 6 vom: 01. Juni, Seite 954-962 |w (DE-627)NLM077783093 |x 1520-5762 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2021 |g number:6 |g day:01 |g month:06 |g pages:954-962 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/03639045.2021.1957916 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 47 |j 2021 |e 6 |b 01 |c 06 |h 954-962 |